Samalin Investment Counsel’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $301K | Buy |
|
|||||
|
2025
Q2 | $275K | Sell |
|
|||||
|
2025
Q1 | $554K | Buy |
|
|||||
|
2024
Q4 | $539K | Sell |
|
|||||
|
2024
Q3 | $832K | Buy |
|
|||||
|
2024
Q2 | $723K | Buy |
|
|||||
|
2024
Q1 | $657K | Sell |
|
|||||
|
2023
Q4 | $619K | Sell |
|
|||||
|
2023
Q3 | $584K | Sell |
|
|||||
|
2023
Q2 | $516K | Sell |
|
|||||
|
2023
Q1 | $623K | Sell |
|
|||||
|
2022
Q4 | $550K | Sell |
|
|||||
|
2022
Q3 | $561K | Buy |
|
|||||
|
2022
Q2 | $456K | Sell |
|
|||||
|
2022
Q1 | $670K | Hold |
|
|||||
|
2021
Q4 | $606K | Hold |
|
|||||
|
2021
Q3 | $580K | Buy |
|
|||||
|
2021
Q2 | $511K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $37K | Buy |
|